Print

Achillion Pharmaceuticals, Inc. (ACHN) Reports Second Quarter and Six Month 2012 Financial Results  
8/8/2012 9:28:23 AM

NEW HAVEN, Conn., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and six months ended June 30, 2012 and provided an update on the Company's portfolio of clinical stage compounds being developed for the treatment of hepatitis C virus (HCV).
//-->